Intermediatedivision
Cyclins and CDKs: The Molecular Engine of the Cell Cycle
Overview
Cyclins and cyclin-dependent kinases are the gears of the cell cycle. This guide explains how each cyclin type — D, E, A, and B — rises and falls in turn, partnering with its CDK to phosphorylate the targets that launch the next phase. You will learn how CDKs are switched on by cyclin binding and activating phosphorylation, switched off by inhibitory phosphorylation and CDK inhibitors such as p16, p21, and p27, and why the ordered destruction of cyclins makes the cycle a one-way ratchet.
Learning objectives
- Name the four main cyclin types and the cell-cycle phase each one drives.
- Explain how CDKs are activated by cyclin binding and phosphorylation.
- Describe how CDK inhibitors (p16, p21, p27) halt the cycle.
- Explain why cyclin destruction makes the cell cycle irreversible.
Structure and function
| Part | Structure | Function |
|---|---|---|
| Cyclin D | G1 cyclin; accumulates in response to growth-factor signaling. | Partners with CDK4/6 to phosphorylate Rb, releasing the E2F transcription factor that switches on S-phase genes. |
| Cyclin E | Late-G1 cyclin; peaks at the G1/S boundary. | With CDK2, completes Rb phosphorylation and fires the origins of replication, committing the cell to DNA synthesis. |
| Cyclin A | S-phase cyclin; present through S and G2. | With CDK2/CDK1, drives DNA replication and prevents re-firing of origins so the genome is copied exactly once. |
| Cyclin B | Mitotic cyclin; accumulates through G2 and peaks in M. | With CDK1 forms the maturation-promoting factor (MPF) that triggers chromosome condensation, nuclear envelope breakdown, and spindle assembly. |
| CDK inhibitor p21 | Protein induced by p53 after DNA damage; binds G1/S cyclin-CDK complexes. | Broad brake on the cycle that enforces checkpoint arrest until damage is repaired. |
| Anaphase-promoting complex (APC/C) | Ubiquitin ligase that tags cyclins (and securin) for proteasomal destruction. | Its activation destroys cyclin B to exit mitosis and resets the cycle for the next G1. |
Diagram: a wave graph with the cell-cycle phases on the x-axis and cyclin concentration on the y-axis. Four colored waves peak in sequence: cyclin D in G1, cyclin E at G1/S, cyclin A across S/G2, cyclin B in M. Each wave is paired with a labeled CDK gear icon. A trash-can icon labeled APC/C sits at the end of each wave, showing destruction. A red brake symbol labeled p21/p27 points at the G1 waves.
CDKs: engines that need a key
Cyclin-dependent kinases are present at roughly constant levels throughout the cycle, but on their own they are inactive — the active site is blocked and the activation loop is mispositioned. They become functional only when the right cyclin binds, which reshapes the active site, plus a phosphate added to the activation loop by CDK-activating kinase (CAK). Think of the CDK as an engine and the cyclin as the ignition key: the engine is always there, but it only runs when the key for that phase is inserted.
The cyclin wave: D, E, A, B
Cyclin abundance oscillates because each cyclin is synthesized in its phase and destroyed afterward. Cyclin D rises in G1 under growth-factor signaling and pairs with CDK4/6. Cyclin E peaks at the G1/S boundary with CDK2 to launch replication. Cyclin A operates through S and G2 with CDK2 (then CDK1). Cyclin B accumulates in G2 and, with CDK1, forms MPF — maturation-promoting factor — the trigger for mitosis. This ordered sequence is the timetable of the cycle.
D = G1 growth signaling, E = G1/S transition and origin firing, A = S phase replication, B = mitosis. Exam questions often ask which cyclin-CDK pair acts at which boundary.
Switching CDKs on and off: phosphorylation
Beyond cyclin binding, CDKs carry two regulatory phosphate sites. Wee1 kinase adds inhibitory phosphates that keep cyclin B-CDK1 silent during G2, and the phosphatase Cdc25 removes them to unleash mitosis — this is exactly the switch the G2 checkpoint controls. Meanwhile, CAK adds an activating phosphate to the T-loop. Full activation therefore requires the right cyclin, removal of inhibitory phosphates, and addition of the activating phosphate: three independent locks on one engine.
The brakes: CDK inhibitors
Two families of inhibitors can stop the engine. The INK4 family (p16 is the classic member) specifically blocks CDK4/6, preventing Rb phosphorylation and holding cells in G1 — p16 accumulates in aging cells and enforces senescence. The Cip/Kip family (p21, p27) binds broadly to cyclin-CDK complexes: p21 is induced by p53 after DNA damage, while p27 enforces quiescence in G0 and is degraded when growth signals arrive. Inhibitors are how checkpoints and external signals physically halt the cycle.
p16: INK4 family, blocks CDK4/6, senescence and aging. p21: Cip/Kip, induced by p53 after DNA damage. p27: Cip/Kip, maintains G0 quiescence. Mixing these up is a classic exam trap.
Why the cycle only moves forward
At the end of each phase, the APC/C ubiquitin ligase tags that phase's cyclin for destruction by the proteasome. Destroyed cyclin B, for example, shuts off MPF and forces mitotic exit — the cell cannot re-enter mitosis until fresh cyclin B is synthesized in the next G2. Because the key is thrown away after each use, the cycle is a ratchet: G1 → S → G2 → M, never backward. This irreversibility is what makes cell division orderly rather than chaotic.
Cyclins, CDKs, and cancer therapy
Many cancers hijack this engine: cyclin D is overexpressed, CDK4/6 is hyperactive, or p16 is deleted. Drugs called CDK4/6 inhibitors (used against certain breast cancers) work by re-applying the brake that the tumor removed, holding cancer cells in G1. Understanding which cyclin-CDK pair drives which transition is therefore not just exam material — it is the basis of a real class of cancer drugs.
Key points
- CDKs are always present but inactive; they switch on only when their phase-specific cyclin binds.
- The cyclin wave runs D (G1) → E (G1/S) → A (S/G2) → B (M), each driving its phase's events.
- Wee1/Cdc25 control inhibitory phosphates on CDK1; CAK adds the activating phosphate.
- CDK inhibitors p16, p21, and p27 apply the brakes for senescence, DNA damage, and quiescence.
- APC/C destroys cyclins after use, making the cycle an irreversible one-way ratchet.
- CDK4/6 inhibitors treat cancers by restoring the G1 brake.
Common misconceptions
✓ Truth: CDK protein levels stay roughly constant. It is the cyclins that oscillate — synthesized and destroyed each cycle — and their binding is what switches CDKs on and off.
✓ Truth: The INK4 family (p16) specifically blocks CDK4/6, while the Cip/Kip family (p21, p27) binds a broad range of cyclin-CDK complexes. They respond to different signals: senescence, DNA damage, and quiescence respectively.
✓ Truth: On CDKs, phosphorylation has opposite effects at different sites: CAK's phosphate on the activation loop turns the kinase on, while Wee1's phosphates on other residues hold it off until Cdc25 removes them.
Practice questions
Q1. Cyclin D pairs primarily with which CDKs to drive early G1 progression?
- CDK1 and CDK2
- CDK4 and CDK6
- CDK7 only
- CDK2 and CDK1
Growth-factor signaling induces cyclin D, which binds CDK4 and CDK6. These complexes phosphorylate Rb, releasing E2F to switch on S-phase genes. CDK2 partners with cyclins E and A; CDK1 partners with cyclins A and B.
Q2. Wee1 kinase keeps cyclin B-CDK1 inactive during G2 by:
- Degrading cyclin B
- Adding inhibitory phosphates to CDK1
- Blocking cyclin B synthesis
- Activating the APC/C
Wee1 adds inhibitory phosphates to CDK1, holding MPF silent through G2. At the G2/M transition, the phosphatase Cdc25 removes these phosphates, unleashing mitosis. This is the switch the G2 checkpoint guards.
Q3. A cell that cannot produce p16 would have trouble with:
- Firing origins of replication
- Enforcing senescence and the G1 brake on CDK4/6
- Attaching kinetochores to microtubules
- Synthesizing cyclin B in G2
p16 is an INK4-family inhibitor that specifically blocks CDK4/6. Without it, Rb gets phosphorylated too easily and cells slip past the G1 brake — a common defect in cancers and a failure of senescence enforcement.
Click a question to reveal the answer and explanation.
Frequently asked questions
Why is it useful that CDKs are always present but inactive?
It makes the cycle fast and responsive. The cell does not waste time synthesizing new kinase for each phase; it only needs to make the cyclin key. Regulation then happens through quick binding, phosphorylation, and destruction events rather than slow protein synthesis.
What would happen if cyclin B were never destroyed?
MPF (cyclin B-CDK1) would stay active, so the cell could not exit mitosis — chromosomes would remain condensed and the nuclear envelope could not reform. Cyclin destruction is what forces mitotic exit and resets the cycle, which is why APC/C activation is the point of no return for leaving M phase.
How does p16 differ from p21 in enforcing a G1 arrest?
p16 belongs to the INK4 family and specifically inhibits CDK4/6, blocking Rb phosphorylation; it accumulates during cellular senescence and aging. p21 belongs to the Cip/Kip family, is induced by p53 after DNA damage, and broadly inhibits G1/S cyclin-CDK complexes. Different signals, different specificities, same outcome: G1 arrest.
What does MPF do, and what is it made of?
MPF, maturation-promoting factor, is the cyclin B-CDK1 complex. When activated at the G2/M boundary, it phosphorylates the proteins that condense chromosomes, break down the nuclear envelope, and assemble the spindle — in short, it triggers mitosis. Its destruction by APC/C later allows mitotic exit.